In most cases, neuronal diseases can only be diagnosed on the basis of symptoms and medical imaging. This is why procedures such as magnetic resonance imaging (MRI) are of central importance in neurological treatments. It provides fundamental information for the diagnosis and understanding of neuronal diseases and thus also for the development of effective treatment methods and the long-term monitoring of treatment success. The ThINk Basel research group is working on the continuous improvement of neuronal imaging by improving existing technologies and methods, but also by developing new ones. Our researchers are particularly specialized in the untapped potential of magnetic resonance imaging in the research and diagnosis of multiple sclerosis. In multiple sclerosis research, the ThINk team identifies biomarkers, develops computer-aided methods to more accurately track the progression of the disease and studies structural regeneration processes. The ThINk Group also uses its expertise to research the complex causes of headaches, migraines, strokes and neuro-HIV, among other things. The entire diversity of research topics covered by ThINk can be seen on the individual project pages.